Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

NORML
norml.org > news > 09/10/2026 > analysis-nearly-7-in-10-patients-with-seizure-disorders-report-decreased-seizure-frequency-after-using-state-authorized-medical-cannabis-products

Nearly 7 in 10 Report Fewer Seizures With Medical Cannabis

2+ day, 14+ hour ago   (208+ words) NORML Minneapolis, MN: Patients suffering from seizure-related disorders, such as epilepsy, report decreases in their seizure frequency following their use of state-authorized medical cannabis products, according to data published in the journal Epilepsy & Behavior. Investigators with the University of Minnesota…...

NORML
norml.org > news > 08/27/2026 > clinical-trial-cbd-dominant-extracts-reduce-pain-from-burning-mouth-syndrome

CBD Reduces Pain From Burning Mouth Syndrome

2+ week, 2+ day ago   (222+ words) Curitiba, Brazil: The administration of CBD-dominant cannabis extracts significantly reduces pain in patients suffering from oral dysesthesia (a chronic painful burning sensation in the mouth absent any identifiable cause), according to randomized, placebo-controlled clinical trial data published in the journal…...

Google News
norml.org > news > 08/20/2026 > survey-older-veterans-frequently-report-cannabis-use

Survey: Older Veterans Frequently Report Cannabis Use

3+ week, 2+ day ago   (230+ words) San Francisco, CA: Veterans over the age of 50 are more likely than non-veterans to self-report using cannabis, according to survey data published in the Journal of General Internal Medicine. Researchers affiliated with the University of California at San Francisco assessed…...

NORML
norml.org > news > 08/20/2026 > clinical-trial-plant-derived-cbd-extract-improves-ocd-symptoms

CBD Improves OCD Symptoms in Clinical Trial

3+ week, 2+ day ago   (206+ words) Tehran, Iran: The daily use of plant-derived CBD oral extracts mitigates symptoms in patients diagnosed with obsessive-compulsive disorder (OCD), according to randomized, placebo-controlled clinical trial data published in the journal Annals of Indian Psychiatry. Iranian investigators assessed the efficacy of…...

NORML
norml.org > news > 08/13/2026 > clinical-trial-oral-cbd-mitigates-post-surgery-ocular-pain-as-effectively-as-opioids

Cannabis Relieves Post-Surgery Eye Pain as Effectively as Opioids

4+ week, 2+ day ago   (200+ words) Gainesville, FL: Plant-derived CBD provides pain relief in a manner comparable to opioids in patients recuperating from eye surgery, according to clinical trial data published in the Journal of Cataract & Refractive Surgery. Researchers affiliated with the University of Florida Department…...

NORML
norml.org > news > 08/13/2026 > study-endometriosis-patients-experience-sustained-improvements-from-medical-cannabis-reduce-their-opioid-use

Medical Cannabis Provides Relief for Endometriosis Symptoms

4+ week, 2+ day ago   (250+ words) norml.org London, United Kingdom: The sustained use of medical cannabis preparations provides safe and effective relief for endometriosis patients, according to observational data published in the Australian and New Zealand Journal of Obstetrics and Gynecology. British researchers assessed the…...

NORML
norml.org > news > 08/13/2026 > georgia-enrollment-in-states-medical-cannabis-access-program-spikes-following-law-change

Georgia's Medical Cannabis Program Enrollment Spikes

4+ week, 2+ day ago   (170+ words) Atlanta, GA: The number of Georgians enrolled in the state’s medical cannabis access program has increased more than 20 percent since lawmakers expanded the law in May. Senate Bill 220: The Putting Georgia’s Patients First Act, which took effect on July 1st, permits…...

NORML
norml.org > blog > 08/11/2026 > norml-op-ed-high-time-to-remove-cannabis-from-schedule-i-status > amp

NORML Op-Ed: High Time to Remove Cannabis from Schedule I Status NORML Op-Ed: High Time to Remove Cannabis from Schedule I Status

1+ mon, 1+ day ago   (236+ words) Removing cannabis from its Schedule I classification and acknowledging are legitimate therapeutic utility is appropriate and long overdue. The Department of Health and Human Services acknowledged in 2023 that cannabis should be federally reclassified from Schedule I to Schedule III. That’s because…...

NORML
norml.org > blog > 08/10/2026 > clinical-trial-plant-derived-cannabis-preparation-is-safe-and-effective-in-children-with-autism

Clinical Trial: Plant-Derived Cannabis Preparation Is Safe and Effective in Children with Autism Clinical Trial: Plant-Derived Cannabis Preparation Is Safe and Effective in Children with Autism

1+ mon, 2+ day ago   (364+ words) Clinical Trial: Plant-Derived Cannabis Preparation Is Safe and Effective in Children with Autism NORML The twice daily administration of a standardized cannabis extract is safe and provides clinically meaningful improvements in children and adolescents with autism spectrum disorder (ASD), according…...

NORML
norml.org > news > 08/06/2026 > analysis-medical-cannabis-access-associated-with-improved-mental-health-among-older-adults

Better Mental Health for Seniors With Medical Cannabis Access

1+ mon, 6+ day ago   (223+ words) Pittsburgh, PA: Older adults report improvements in their mental health following the opening of medical cannabis dispensaries in their neighborhoods, according to data published in the journal Economic Letters and recently provided by PubMed Central. Researchers affiliated with the University…...